Other Information.
+Added: On August 8, 2022, we entered into an amendment (the “Lease Amendment”) to the lease agreement for office and lab space at Chestnut Run Plaza in Wilmington, Delaware (the “Chestnut Run Lease”).
+Added: The Chestnut Run Lease commences on the earlier of (i) the Landlord Work Substantial Completion Date (as such term is defined in the Chestnut Run Lease), or (ii) the date the Company takes possession of the premises for the conduct of the Company’s business.
+Added: The Lease Amendment increases the monthly base rent payments due over the initial term of the Chestnut Run Lease to approximately $42.6 million.
+Added: The foregoing summary of Lease Amendment does not purport to be complete and is subject to, and qualified in its entirety by, the complete text of the lease, a copy of which we expect to file with our Quarterly Report on Form 10-Q for the quarterly period ending September 30, 2022.
Furnish the exhibits required by Item 601 of Regulation S-K (§ 229.601 of this chapter).
1 unchanged sentence
Filed/Furnished Herewith
−Removed: Executive Employment Agreement, dated January 21, 2022, by and between the Registrant and Jane Huang
+Added: Separation Agreement, dated April 6, 2022, between the Registrant and Deborah Morosini, M.D.
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
12 unchanged sentences
* The certifications furnished in Exhibits 32.1 and 32.2 hereto are deemed to accompany this Form 10-Q and are not deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall they be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act .
+Added: †Indicates management contract or compensatory plan or arrangement.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Prelude Therapeutics Incorporated
+Added: August 9, 2022
/s/ Krishna Vaddi
2 unchanged sentences
(Principal Executive Officer)
+Added: August 9, 2022
/s/ Laurent Chardonnet
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.